Bright Minds Biosciences (NASDAQ:DRUG) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Bright Minds Biosciences (DRUG) operate in?

Bright Minds Biosciences is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Bright Minds Biosciences Stock (NASDAQ: DRUG) stock price, news, charts, stock research, profile.

Open	$38.39
Close	$38.65
Volume / Avg.	51.87K / 2.97M
Day Range	$36.81 - $39.10
52 Wk Range	0.93 - 79.02
Market Cap	$226.91M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	4.26%
Days to Cover	1.04

Recent News

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?

A look at the most-searched tickers on Benzinga Pro for the month of October. Donald Trump and biotech stocks joined the top 10.

Chris Katje

What's Going On With Bright Minds Biosciences Stock?

Bright Minds Biosciences Inc (NASDAQ:DRUG) shares are trading higher again after soaring last week. The company on Monday announced a new collaboration with brain health-focused AI company Firefly Neuroscience.

Adam Eckert

MarketBeat Week in Review – 10/14 - 10/18

Stocks struggled to find direction in a week that lacked significant news to move the markets, but the bias remains to move higher. Retail sales came in slightly better than expected, but when adjusted for inflation, the

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.7

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$38.39
Close	$38.65
Volume / Avg.	51.87K / 2.97M
Day Range	$36.81 - $39.10
52 Wk Range	0.93 - 79.02
Market Cap	$226.91M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	4.26%
Days to Cover	1.04

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Bright Minds Biosciences (DRUG) stock?

You can purchase shares of Bright Minds Biosciences (NASDAQ:DRUG) through any online brokerage.

View our list of the best stock brokerages

Who are Bright Minds Biosciences (DRUG) competitors?

There are no as such competitors for Bright Minds Biosciences.

What is the forecast, or price target, for Bright Minds Biosciences (DRUG) stock?

Bright Minds Biosciences has a consensus price target of $75.00.

What is the current price for Bright Minds Biosciences (DRUG)?

The stock price for Bright Minds Biosciences (NASDAQ: DRUG) is $37.34 last updated December 20, 2024 at 7:00 PM EST.

Does Bright Minds Biosciences (DRUG) pay a dividend?

There are no upcoming dividends for Bright Minds Biosciences.

When is Bright Minds Biosciences (NASDAQ:DRUG) reporting earnings?

Bright Minds Biosciences’s Q1 earnings are confirmed for Tuesday, February 11, 2025.

Is Bright Minds Biosciences (DRUG) going to split?

There is no upcoming split for Bright Minds Biosciences.

What sector and industry does Bright Minds Biosciences (DRUG) operate in?

Bright Minds Biosciences is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Bright Minds Biosciences

Bright Minds Biosciences (DRUG) Forecast